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Beneficial molecular and neuroplastic changes have been demonstrated in response
to environmental enrichment (EE) in laboratory animals across the lifespan. Here, we
investigated whether these effects extend to C-type Natriuretic Peptide (CNP), a widely
expressed neuropeptide with putative involvement in neuroprotection, neuroplasticity,
anxiety, and learning and memory. We determined the CNP response in 36 young
(8–9 months) and 36 aged (22–23 months) male PVGc hooded rats that were rehoused
with new cage mates in either standard laboratory cages or EE for periods of 14
or 28 days. Tissues were rapidly excised from four brain regions associated with
memory formation (dorsal hippocampus, retrosplenial cortex, medial prefrontal cortex,
and mammillary bodies) plus the occipital cortex and hypothalamus, and immediately
frozen. Radioimmunoassay was used to measure bioactive CNP and the amino-terminal
fragment of proCNP, NTproCNP. Because CNP but not NTproCNP is rapidly degraded
at source, NTproCNP reflects CNP production whereas the ratio NTproCNP:CNP is a
biomarker of CNP’s local degradation rate. EE increased CNP at 14 days in all brain
regions in young, but not old rats; this effect in young rats was lost at 28 days in all
regions of interest. NTproCNP:CNP ratio, but not NTproCNP, was reduced in all regions
by EE at 14 days in young rats, but not in old rats, which suggests a period of reduced
degradation or receptor mediated clearance, rather than increased production of CNP
in these young EE rats. Aged rats tended to show reduced NTproCNP:CNP ratios but
this did not occur in dorsal hippocampus or mammillary bodies. This is the first study
demonstrating modulation of CNP protein concentrations, and the effect of age, in
response to environmental stimulation. Furthermore, it is the first to show that changes in
degradation rate in vivo may be an important component in determining CNP bioactivity
in neural tissues.
Keywords: C-type natriuretic peptide, environmental enrichment, aging, medial prefrontal cortex, hippocampus,
retrosplenial cortex
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INTRODUCTION
Multiple beneficial effects of Environmental Enrichment (EE)
have been established over 60 years of research using the
paradigm. These variously occur at molecular, cellular and
behavioral levels and relate to neurogenesis, synaptic plasticity,
neuroprotection, and modifications to anxiety and learning and
memory across the lifespan (see Rosenzweig and Bennett, 1996;
van Praag et al., 2000; Will et al., 2004; Nithianantharajah
and Hannan, 2006; Clemenson et al., 2015 for selected
reviews). Less well-established is the neurological action of C-
type Natriuretic Peptide (CNP), a proposed neuroendocrine
regulator, with similar associations to those effects modified by
EE.
CNP is the most recently discovered, but most primitive
member of the Natriuretic Peptide family alongside Atrial
and B-type Natriuretic Peptides. The family shares a ring
structure consisting of 17 amino acid residues, flanked by two
cysteine residues forming a disulfide bond critical to biological
activity (Pandey, 2005; Potter et al., 2006). Three forms of
the peptide occur: expression of the Nppc (Natriuretic Peptide
Precursor-C) gene elicits the initial 126 residue preproCNP
(Tawaragi et al., 1990) resulting in the 103 residue proCNP,
which is cleaved intracellularly to produce CNP-53 and a
biologically inactive amino terminal fragment, NTproCNP, both
of which are secreted extracellularly in equimolar amounts (Wu
et al., 2003; Prickett and Espiner, 2012). Further extracellular
processing results in CNP-22, thought to be the fully active
form of the peptide, with CNP-53 proposed as a storage form
(Barr et al., 1996). CNP-22 is the most highly conserved of
the Natriuretic Peptide family and is identical in all mammals
studied to date (Pandey, 2005; Potter, 2011). CNP binds to
a specific receptor, Natriuretic Peptide Receptor-B (NPR-B),
through which it increases intracellular concentrations of cyclic
Guanosine Monophosphate (cGMP; Yeung et al., 1996; Potter
et al., 2006; Potter, 2011). Regulation of the peptide occurs via
a membrane bound clearance receptor (NPR-C), which clears all
Natriuretic Peptides from the extracellular space; and proteolytic
degradation by neprilysin (primarily) and insulin degrading
enzyme (Müller et al., 1992; Kenny et al., 1993; Watanabe et al.,
1997; Potter, 2011).
It is important to note that the concentration of CNP at
any time point is a function of both production and clearance
or degradation rates. Since NTproCNP is not subject to rapid
degradation or clearance (half-life of 30–40min compared with
2–3min for CNP), it provides a reliable measure of NPPC
gene expression and peptide production (Schouten et al., 2011;
Woodward et al., 2017). Calculation of NTproCNP:CNP ratio
(by taking NTproCNP/CNP concentrations) provides an index
of CNP’s clearance or degradation in the tissue sampled, either
via NPR-C mediated internalization or hydrolysis by neprilysin.
Higher ratios reflect increases in the rate of loss of the
bioactive form of the peptide. Combined measurement of CNP
and NTproCNP, with calculation of the ratio, allows separate
contributions of peptide production and metabolic clearance to
be determined.
High concentrations of CNP are found in brain tissue, with
the peptide constituting the major neuroactive member of the
natriuretic peptide family (Komatsu et al., 1991; Kaneko et al.,
1993; Totsune et al., 1994; Langub et al., 1995a; Pemberton et al.,
2002; Jankowski et al., 2004; Wilson et al., 2017). In rodents, both
CNP and NPR-B mRNA occur variably throughout olfactory
bulb, basal forebrain, basal ganglia, limbic cortices, thalamus,
amygdala, mammillary nuclei, hippocampus, and cerebellum
(Langub et al., 1995a,b; Herman et al., 1996). As CNP is widely
accepted to act in a paracrine/autocrine fashion, this regional
distribution suggests a role for the peptide in the integration of
sensation and emotion into memory.
This hypothesis receives initial support from the relatively
sparse literature regarding CNP’s effects within brain, and
on behavior. Additionally, these findings indicate similarities
between CNP’s action and the beneficial effects of EE specifically
in terms of neurogenesis, neuroplasticity, modification of anxiety
behaviors, learning and memory. CNP induces a switch from
proliferation to maturation in olfactory neuronal precursors
(Simpson et al., 2002), is necessary for bifurcation of sensory
axons (Schmidt et al., 2007, 2009; Zhao and Ma, 2009)
and is associated with the onset of neurogenesis within the
developing nervous system (DiCicco-Bloom et al., 2004). Within
retinal ganglion cells, CNP is neuroprotective against cytotoxic
injury both in vivo and in vitro (Ma et al., 2010). Within
the hippocampus, CNP modifies several electrophysiological
correlates of synaptic plasticity, and notably impedes long-
term potentiation while facilitating long-term depression within
CA1 (Decker et al., 2008, 2009, 2010). In relation to anxiety
behavior, CNP may have a bidirectional effect as it is anxiolytic
in low dose ranges, but anxiogenic when higher doses are
administered (Bíró et al., 1996; Montkowski et al., 1998; Jahn
et al., 2001). Such a bidirectional effect may also occur in
relation to learning and memory behaviors: CNP improves
learning in a passive avoidance task (Telegdy et al., 1999; Telegdy
et al., 2000), but functional downregulation of NPR-B receptor
signaling is associated with improved object-recognitionmemory
(Barmashenko et al., 2014). Based on these emerging similarities
between CNP’s effects and effects demonstrated in EE, we posited
that the paradigmwould provide an excellent context for study of
CNP within brain tissue.
In addition to a possible effect of EE on CNP, it has been
recently suggested that Natriuretic Peptides may be involved in
cognitive impairment and pathologies related to aging (Mahinrad
et al., 2016). Although no relationship was previously found
between age and CNP concentration in cerebrospinal fluid
across a specific age-range in Parkinson’s Disease patients (51–
90 years; Schouten et al., 2011; Espiner et al., 2014), this
does not exclude the possibility that regional variations may
still be found within cerebral tissue. A primary question is
whether CNP expression or degradation within brain tissue
varies during normal aging. To this end, we analyzed brain
tissue of both young and aged rats housed in either standard or
enriched cages for two different periods of housing, selected to
be representative of shorter- and longer-term exposure typical
of many enrichment studies (Simpson and Kelly, 2011). Given
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previously demonstrated reductions of neprilysin in fronto-
temporal regions with brain aging (Iwata et al., 2002; Apelt
et al., 2003; Fjell et al., 2014), general reductions to the
NTproCNP:CNP ratio were expected in aged rats. As this is the
first study of its kind, no predictions could be made about how
enriched housing may affect concentrations of CNP, or synthesis




Thirty-six male PVGc hooded rats aged 8–9 months old (weights
between 306 and 413 g) and 36 male PVGc hooded rats aged
22–23 months (weights between 293 and 440 g) at the start of
enrichment were treated equivalently in all respects. Prior to
enrichment, all rats were housed in standard opaque plastic cages
(45× 27× 22 cm high) in groups of three or four, from weaning
until placement in enrichment at the stated ages. For each age
group, on the first day of enrichment, 24 rats were re-housed
in two enrichment cages (12 per cage) for either 14 or 28 days
(1 cage per time-period; Enriched-14-day and Enriched-28-day).
Twelve remaining rats were re-housed with new cage mates in
standard cages (3 rats per cage) for the same time periods (2
cages per time-period; 6 rats total per time-period; Standard-
14-day and Standard-28-day). All rats were rehoused with novel
cage mates. Rats were maintained on a reversed light-dark cycle
(lights off 08:00–20:00 h) and colony rooms were maintained at
22◦C and 48% relative humidity. Food and water were available
ad libitum. All procedures conformed to the NIH guide for the
care and use of laboratory animals and were approved by the
University of Canterbury Animal Ethics Committee.
Enrichment
A standardized enrichment protocol developed at the University
of Canterbury was used (Harland et al., 2014; and see http://www.
psyc.canterbury.ac.nz/Standardized%20Enrichment.shtml for
details of, objects, arrangements and procedures). Enrichment
cages were made of wire mesh with a sawdust covered metal
floor and measured 85 cm x 60 cm x 30 cm high. Each day
of enrichment consisted of a different combination of “junk”
objects such as ceramic figurines, metal chains, PVC pipes and
junctions and other small items, along with an ever-present
wooden block to discourage chewing of enrichment objects.
Enrichment configurations differed over 40 different days
(though a maximum of 28 was used here) and ensured no object
was repeated within 5 days of itself. On every seventh day, PVC
pipes and junctions were presented in a “tubing only” day, and
on every eighth day, all objects (except the wooden blocks) were
removed from the cage. Additionally, food and water positions
were changed daily, and cages were rotated through one of four
possible positions in the colony room every fourth day. Objects
were changed at the start of the dark period (between 09:00
and10:00h), during which rats from one enrichment cage were
held together in a large opaque plastic cage (62 × 40 × 22 cm
high).
Sacrifice and Tissue Extraction
After either 14 or 28 full days of enrichment, or the same period
of standard housing with new cage mates, rats were placed in
standard cages at the same time enrichment objects were usually
changed and held in a novel, dimly lit room separate to both the
colony room and tissue dissection room. Rats from Enriched and
Standard Housing were euthanised throughout a single day, with
two Enriched rats sacrificed per one Standard Housed, and order
of sacrifice randomized within these groups of three. Rats were
deeply anesthetised with an overdose of Sodium Pentobarbitone
(1mL, 300 mg/mL, ip). Once unresponsive to both tail pinch and
plantar reflex (∼5min following injection), with no discernible
heartbeat, rats were decapitated, and brains rapidly removed
from the skull and placed in a brain matrix (Ted Pella). An initial
coronal cut was made at the level of the optic tract. Additional
coronal cuts were made 5mm anterior and posterior to the
initial cut, resulting in two “slabs” of fresh tissue (anterior extent
approximately equivalent to Bregma +3.20mm; posterior extent
approximately equivalent to Bregma −6.30mm; from the atlas
of Paxinos and Watson, 1998). These tissue slabs were placed
anterior-face-upwards on a glass petri dish, previously sterilized
with 70% ethanol and rinsed with saline. Sterilization and rinsing
was repeated between rats. Microdissection scissors were used
to acquire tissue samples from seven regions of interest, starting
in the posterior slab, in the order: occipital cortex, retrosplenial
cortex (containing both dysgranular and granular B tissue),
dorsal hippocampus (left and right hemispheres separately),
mammillary bodies, hypothalamus and medial prefrontal cortex.
Tissue samples were placed in pre-weighed Eppendorf tubes,
weighed, and snap frozen with liquid nitrogen, within 15min
post-sacrifice, before long-term storage at−80◦C.
Tissue Preparation and Peptide
Measurements
CNP and NTproCNP were measured by radioimmunoassay
(RIA), described in detail in (Yandle et al. (1993) CNP) and
(Yandle et al. (1993) NTproCNP). Prior to assay, frozen tissue
samples were transferred to dry ice chilled scintillation vials, then
10mL of boiling distilled water containing 0.01% Triton X-100
was added and the vials were held at 98◦C in a water bath for
5min. Samples were acidified with 610 µL glacial acetic acid
and homogenized prior to extraction on Sep-Pak C18 cartridges
(Waters Corporation, Milford, MA, USA). Following extraction,
samples were dried under an air stream and frozen for later re-
suspension in assay buffer for RIA. All tissues from an individual
rat were processed in the same extraction, with tissues from
housing groups counterbalanced across extractions.
CNP Assay
CNP-22 is identical in all mammals studied thus far. CNP-22
and the amino terminal extended form CNP-53, both contain
the 17-amino acid ring essential for bioactivity and show 100%
cross reactivity in the assay used to measure CNP. Antiserum
to CNP-22 (G-012-03, Phoenix Pharmaceuticals, Belmont, CA)
was diluted 1:2,000 with assay buffer. Labeled CNP was prepared
by chloramine-T iodination of [Tyr0] CNP-22 (Peninsula Labs)
and purified by reverse-phase HPLC. Fifty microliters each of
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antiserum and CNP standard (0.7–235 pmol/L) or sample extract
(all in duplicate) were mixed and incubated for 22–24 h at 4◦C,
followed by addition of 50 µL labeled CNP containing 2,000 cpm
for 22–24 h at 4◦C. Bound and free labeled CNP were separated
by a solid-phase secondary antibody method (Sac-cell, Rabbit-
Anti Goat, IDS Ltd., England). CNP assays had a detection limit
of 0.6 pmol/L and ED50 of 7.3 pmol/L; intra- and inter-assay
coefficients of variation were 5.9 and 7.4%, respectively, at 17
pmol/L.
NTproCNP Assay
For NTproCNP an in-house antiserum was used that recognizes
the C-terminal epitope in the region of proCNP (38–50), which
is identical in human, mouse, and rat (Prickett et al., 2012). Fifty
microliters of sample extract or 0.5–372 pmol/L proCNP(36–
50) standards (again in duplicate) were incubated with 50 µL
ovine antiserum (Sheep43) for 22–24 h, followed by addition of
50 µL tracer solution (proCNP(38-50)-[125I]Tyr37) containing
2,000 cpm for 22–24 h at 4◦C. Bound and free labeled proCNP
were separated by solid-phase second antibody method (Sac-
cell, Donkey-Anti Sheep, IDS Ltd., England). NTproCNP assays
had a detection limit of 0.4 pmol/L and ED50 9.9 pmol/L;
intra- and inter-assay coefficients of variation were 6.8 and 7.5%,
respectively, at 45 pmol/L.
Statistical Analyses
CNP and NTproCNP concentrations were expressed as
femtomoles per gram of wet tissue (fmol/g). NTproCNP:CNP
ratio was calculated by dividing NTproCNP concentration by
CNP concentration. In young rats, CNP assay failed in one
sample from each of retrosplenial (Standard-14-day group)
and occipital (Enriched-14-day group) cortices and data was
excluded, reducing sample Ns in these regions. In aged rats, a
portion of one sample from the hypothalamus (Enriched-28-day
group) was lost, and data subsequently excluded. Two tissue
samples had NTproCNP concentrations beyond the detection
limit of the assay: one frommammillary bodies (Enriched-14-day
group) and one from hypothalamus (Enriched-28-day group).
Thus, sample Ns for aged rats are reduced for each of these
regions (mammillary bodies and hypothalamus). In both age
groups, final Ns for all other regions were: Enriched-14-day,
N = 12; Enriched-28-day, N = 12; Standard-14-day, N = 6;
Standard-28-day, N = 6. Initial analysis indicated there were no
differences in any measure (CNP, NTproCNP or ratio) between
left and right hemispheres of the dorsal hippocampus. Data
was averaged across hemispheres for each rat and analyzed as
a single value. Data acquisition and analysis for Young rats
was conducted prior to acquisition of Aged rat data. As the
Null Hypothesis was rejected in most cases for Young rats (see
results), data from Aged rats were compared directly using
cohen’s d effect sizes. Analysis of data for Young rats was by
Robust 2-way ANOVA with 20% trimmed means (after Mair
and Wilcox, 2016; using WRS2 package for “R”). The statistical
outcome measure of this test—Q—is interpreted in the same
fashion as the traditional F statistic. Post-hoc testing of Young
rats and Aged rat comparisons by effect size (cohen’s d [± 95%
CI]) calculations were all based on trimmed measures (using
compute.es package for “R”). Figures provide boxplots displaying
trimmed mean, standard error and 95% confidence intervals,
overlaid with all data points (constructed using ggplot2 for “R”).
RESULTS
NTproCNP Concentrations
For Young rats, NTproCNP concentrations did not vary in
occipital cortex (Figure 1; overall M [95% CI] = 749.38 [691.36,
807.40]), medial prefrontal cortex (Figure 2; overall M [95%
CI] = 1847.26 [1739.99, 1954.53]), or mammillary bodies
(Figure 4; overall M [95% CI] = 4938.76 [4519.69, 5357.83]).
NTproCNP concentrations also did not vary for Aged rats
in occipital cortex (Figure 1; overall M [95% CI] = 854.61
[801.54, 907.68]), medial prefrontal cortex (Figure 2; overall M
[95% CI] = 1599.42 [1448.72, 1750.12]), or mammillary bodies
(Figure 4; overall M [95% CI] = 4245.68 [3547.89, 4943.48]).
Concentrations of NTproCNP for Aged rats were higher than
for Young rats in occipital cortex (Figure 1; d = 0.62 [0.14,
1.11], p = 0.01), lower than Young rats in medial prefrontal
cortex (Figure 2; d = 0.62 [0.14, 1.10], p = 0.01), and equivalent
in mammillary bodies (Figure 4). In retrosplenial cortex of
Young rats (Figure 3), NTproCNP concentrations were lower
at 14 days after rehousing than 28 days after rehousing, in
Standard cages only (Housing x Time Interaction: Q(1,31) = 6.40,
p = 0.026; Young-Standard-14-day vs. Young-Standard-28-day
(d = 2.12 [0.41, 3.83], p = 0.02). No significant between
group differences were identified for NTproCNP for Aged
rats in retrosplenial cortex (Figure 3). In dorsal hippocampus,
NTproCNP concentrations were lower in Enriched housing than
Standard housing, regardless of Time since rehousing (Figure 5;
Main effect of Housing: Q(1,32) = 7.55, p = 0.017; Young-
Enriched vs. Young-Standard d = 0.87 [0.12, 1.62], p = 0.02).
Again, no effects were identified in Aged rats (Figure 5). In
hypothalamus, NTproCNP concentrations were higher following
14 days of rehousing than 28 days, regardless of Housing
condition (Figure 6; Main effect of TimeQ(1,32) = 11.05, p= 0.01;
Young-14-day vs. Young-28-day d = 1.13 [0.4, 1.86], p < 0.001).
This effect was also not apparent in Aged rats (Figure 6).
CNP Concentrations
For Young rats, significant two-way interactions (Housing ×
Time) were identified in occipital cortex [Q(1,31) = 16.77,
p = 0.001], medial prefrontal cortex [Q(1,32) = 12.56, p = 0.003],
retrosplenial cortex [Q(1,31) = 4.45, p = 0.055] and mammillary
bodies [Q(1,32) = 7.41, p = 0.015]. In each region (Figures 1–
4), CNP concentrations were elevated in Young-Enriched-14-
day rats compared to all other groups of rats (between group
comparisons, Table 1). Additionally, in retrosplenial cortex CNP
concentrations were reduced across time since rehousing for
Standard Housed rats (Young-Standard-14-days vs. Young-
Standard-28-days d = 1.37 [0.21, 2.54], p = 0.02). In dorsal
hippocampus, higher concentrations of CNP were seen 14
days after rehousing with new cage mates, regardless of type
of Housing [Figure 5; Main Effect of Time: Q(1,32) = 5.74,
p = 0.03; Young-14-day vs. Young-28-day d = 0.7 [0,
1.4], p = 0.05]. Although there was no significant effect of
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FIGURE 1 | Concentration (femtomoles/g wet tissue) of NTproCNP (Top), CNP (Middle), and NTproCNP:CNP ratio (Bottom) within occipital cortex. Summary data
is 20% trimmed means (resulting in a reduction of n = 2 for all groups), standard error (box) and 95% confidence interval (whisker), overlaid by individual data points.
For NTproCNP: Aged rats > Young rats. For CNP: Young-Enriched-14-day > Aged overall > Other Young rats. For Ratio: Young-Enriched-14-day < Aged overall <
Other Young rats.
FIGURE 2 | Concentration (femtomoles/g wet tissue) of NTproCNP (Top), CNP (Middle), and NTproCNP:CNP ratio (Bottom) within medial prefrontal cortex.
Summary data is 20% trimmed means (resulting in a reduction of n = 2 for all groups), standard error (box) and 95% confidence interval (whisker), overlaid by
individual data points. For NTproCNP: Aged rats < Young rats. For CNP: Young-Enriched-14-day > Other Young rats; Aged-14-day > Aged-28-day. For Ratio:
Young-Enriched-14-day = Aged overall < Other Young rats.
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FIGURE 3 | Concentration (femtomoles/g wet tissue) of NTproCNP (Top), CNP (Middle), and NTproCNP:CNP ratio (Bottom) within retrosplenial cortex. Summary
data is 20% trimmed means (resulting in a reduction of n = 2 for all groups), standard error (box) and 95% confidence interval (whisker), overlaid by individual data
points. For NTproCNP: Young-Standard-14-day > Young-Standard-28-day. For CNP: Young-Enriched-14-day > Aged overall > Other Young rats. For Ratio:
Young-Enriched-14-day < Aged overall < Other Young rats.
FIGURE 4 | Concentration (femtomoles/g wet tissue) of NTproCNP (Top), CNP (Middle), and NTproCNP:CNP ratio (Bottom) within mammillary bodies. Summary
data is 20% trimmed means (resulting in a reduction of n = 2 for all groups), standard error (box) and 95% confidence interval (whisker), overlaid by individual data
points. For NTproCNP: Aged rats = Young rats. For CNP: Young-Enriched-14-day > Aged overall = Other Young rats. For Ratio: Young-Enriched-14-day < Aged
overall = Other Young rats.
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FIGURE 5 | Concentration (femtomoles/g wet tissue) of NTproCNP (Top), CNP (Middle), and NTproCNP:CNP ratio (Bottom) within dorsal hippocampus. Summary
data is 20% trimmed means (resulting in a reduction of n = 2 for all groups), standard error (box) and 95% confidence interval (whisker), overlaid by individual data
points. For NTproCNP: Young-Enriched < Young-Standard. For CNP: Young-14-day = Aged overall > Young-28-day. For Ratio: Young-Enriched-14-day < Aged
overall = Other Young rats; Young-14-day < Young-28-day.
Housing, highest concentrations of CNP occurred within Young-
Enriched-14-day rats (Figure 5). In hypothalamus, significant
Main Effects of Housing [Q(1,32) = 12.66, p = 0.002] and Time
[Q(1,32) = 21.00, p = 0.001] were such that CNP concentrations
were higher in Enriched rats than Standard Housed rats,
and higher 14 days following rehousing with new cage mates
(Figure 6). The additive nature of these effects was reflected in
significantly higher concentrations of CNP in Young-Enriched-
14-day rats vs. all other groups (between group comparisons,
Table 1).
For Aged rats, CNP concentrations did not vary significantly
in any region, in individual group comparisons (Figures 1–
6). The sole effect on CNP concentrations identified within
Aged rats was in medial prefrontal cortex (Figure 2), wherein
CNP concentrations were higher 14 days after rehousing with
new cage mates than at 28 days of rehousing (d = 0.68
[−0.01, 1.38], p = 0.005). CNP concentrations for Aged rats
overall were lower than the peak seen in Young-Enriched-14-
day rats in occipital cortex, retrosplenial cortex, mammillary
bodies and hypothalamus (between group comparisons,Table 1).
In occipital and retrosplenial cortices (Figures 1, 3), CNP
concentrations were higher in Aged rats than for other Young
rats (i.e., excluding Young-Enriched-14-day rats; between group
comparisons,Table 1). In the Aged hippocampus, concentrations
of CNP were equivalent to Young rats rehoused for 14 days
(d= 0.12 [−0.46, 0.47], ns), but higher than Young rats rehoused
for 28 days (d = −1.01 [−1.62,−0.4], p < 0.001).
NTproCNP:CNP Ratio
For Young rats, significant two-way interactions were identified
in occipital cortex [Q(1,31) = 14.76, p = 0.004], medial
prefrontal cortex [Q(1,32) = 49.00, p= 0.001], retrosplenial cortex
[Q(1,31) = 5.55, p= 0.039] andmammillary bodies [Q(1,32) = 9.20,
p = 0.009]. In each region (Figures 1–4) NTproCNP:CNP ratio
was reduced in Young-Enriched-14-day rats compared with
all other Young rats (between group comparisons, Table 2).
In dorsal hippocampus (Figure 5), NTproCNP:CNP ratio was
lower 14 days following rehousing than at 28 days of rehousing
[Main Effect of Time: Q(1,32) = 15.87, p = 0.003] and lower
in rats housed in Enrichment than in Standard cages [Main
Effect of Housing: Q(1,32) = 7.03, p = 0.026]. Lowest ratio
values therefore occurred in Young-Enriched-14-day rats, but
this difference was not significant compared with Young-
Standard-14-day rats (between group comparisons, Table 2).
In hypothalamus (Figure 6), NTproCNP:CNP ratio was lower
in Enriched rats than Standard Housed rats [Main Effect of
Housing: Q(1,32) = 12.08, p = 0.005]. However, an overall mean
comparison was not statistically significant (Young-Standard vs.
Young-Enriched d = 0.55 [−0.18, 1.28], p = 0.14). Only Young-
Enriched-14-day rats had lower ratio values than Young Standard
Housed rats (between group comparisons, Table 2).
NTproCNP:CNP ratio did not generally vary across groups for
Aged rats (Figures 1–6). Overall, NTproCNP:CNP ratio for Aged
rats was lower than Young rats (excluding Young-Enriched-14-
day rats) in occipital, medial prefrontal and retrosplenial cortices,
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FIGURE 6 | Concentration (femtomoles/g wet tissue) of NTproCNP (Top), CNP (Middle), and NTproCNP:CNP ratio (Bottom) within hypothalamus. Summary data is
20% trimmed means (resulting in a reduction of n = 2 for all groups), standard error (box) and 95% confidence interval (whisker), overlaid by individual data points. For
NTproCNP: Young-14-day > Young-28-day. For CNP: Young-Enriched-14-day > Aged overall = Other Young rats. For Ratio: Young-Enriched-14-day <
Young-Standard. Aged overall < Other Young rats.
TABLE 1 | Between group comparisons (cohen’s d [±95% CI]) for CNP concentrations within five regions of interest (see text for hippocampus and Aged medial
prefrontal cortex).
Region Young SH 14 Young SH 28 Young EE 28 Aged overall
Occipital Cortex Young EE 14 vs. d = 2.14 [0.8, 3.47] *** d = 1.85 [0.57, 3.13]** d = 1.98 [0.92, 3.04]*** d = 1.22 [0.48, 1.96]***
Other Young vs. d = −1.57 [−2.17, −0.97]***
Medial Prefrontal Cortex Young EE 14 vs. d = 1.50 [0.31, 2.68]* d = 1.22 [0.08, 2.36]* d = 1.37 [0.43, 2.31]**
Retrosplenial Cortex Young EE 14 vs. d = 1.35 [0.11, 2.58]* d = 1.84 [0.6, 3.09]** d = 1.32 [0.38, 2.25]** d = 1.31 [0.59, 2.03]***
Other Young vs. d = −1.13 [−1.71, −0.56]***
Mammillary Bodies Young EE 14 vs. d = 1.22 [0.08, 2.36]* d = 1.13 [0.0, 2.26]* d = 1.27 [0.34, 2.19]** d = 1.75 [0.99, 2.52]***
Other Young vs. d = 0.30 [−0.24, 0.83] ns
Hypothalamus Young EE 14 vs. d = 1.11 [0.02, 2.24]* d = 2.17 [0.86, 3.48]*** d = 1.26 [0.33, 2.18]** d = 1.21 [0.49, 1.94]***
Other Young vs. d = −0.45 [−0.99, 0.09] ns
EE, Enriched Environment; SH, Standard Housed; Other Young indicates pooled Young data, excluding Young-Enriched-14-day rats. ***p < 0.001; **p < 0.01; *p < 0.05.
and hypothalamus (between group comparisons, Table 2), but
not in mammillary bodies or dorsal hippocampus.
DISCUSSION
Here, we provide the first data indicating a markedly different
response of CNP and its signaling system in aged compared to
young rats. The major finding in Young rats, is an increased
availability of CNP in all regions of interest following 14 days
of enriched housing, although this effect was weak within
dorsal hippocampus. This increase in CNP can be accounted
for by reduced proteolytic degradation or NPR-C mediated
clearance of the peptide (indicated by NTproCNP:CNP ratio
reductions) as opposed to increased production. Relatively
minimal modifications to peptide production (NTproCNP) were
restricted to tissues from hypothalamus, retrosplenial cortex and
dorsal hippocampus. In contrast, within aged rats changes to
CNP concentrations were restricted to medial prefrontal cortex
and related to rehousing with new cage mates with higher
concentrations of CNP at 14 vs. 28 days of housing regardless
of housing condition. NTproCNP:CNP ratios were reduced
in comparison with young rats generally in occipital cortex,
medial prefrontal cortex, retrosplenial cortex, and hypothalamus
as hypothesized, but this age-related reduction was not
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TABLE 2 | Between group comparisons (cohen’s d [±95% CI]) for NTproCNP:CNP ratio within six regions of interest.
Region Young SH 14 Young SH 28 Young EE 28 Aged overall
Occipital Cortex Young EE 14 vs. d = −4.34 [−6.25, −2.42]*** d = −2.28 [−3.65, −0.92]*** d = −2.0 [−3.07, −0.94]*** d = −1.33 [−2.07, −0.58]***
Other Young vs. d = 0.9 [0.34, 1.45]***
Medial Prefrontal Young EE 14 vs. d = −4.10 [−5.89, −2.30]*** d = −2.64 [−4.05, −1.23]*** d = −3.0 [−4.23, −1.76]*** d = −0.63 [−1.32, 0.05] ns
Cortex Other Young vs. d = 1.52 [0.92, 2.11]***
Retrosplenial Cortex Young EE 14 vs. d = −1.80 [−3.11, −0.49]** d = −1.85 [−3.10, −0.61]** d = −1.69 [−2.67, −0.7]*** d = −1.0 [−1.70, −0.30]**
Other Young vs. d = 1.24 [0.66, 1.82]***
Mammillary Bodies Young EE 14 vs. d = −1.85 [−1.99, −0.60]** d = −1.59 [−2.78, −0.39]** d = −1.20 [−2.12, −0.28]** d = −1.21 [−1.93, −0.49]***
Other Young vs. d = 0.15 [−0.39, 0.68] ns
Hippocampus Young EE 14 vs. d = −0.88 [−1.99, 0.22] ns d = −2.26 [−3.58, −0.93]*** d = −1.31 [−2.25, −0.38]** d = −0.84 [−0.53, 0.15]*
Other Young vs. d = 0.45 [−0.08, 0.99] ns
Hypothalamus Young EE 14 vs. d = −1.82 [−3.06, −0.58]** d = −1.43 [−2.60, −0.25]* d = −0.68 [−1.55, 0.19] ns d = −0.13 [−0.81, 0.55] ns
Other Young vs. d = 0.77 [0.21, 1.32]**
EE, Enriched Environment; SH, Standard Housed; Other Young indicates pooled Young data, excluding Young-Enriched-14-day rats. ***p < 0.001; **p < 0.01; *p < 0.05.
evident in mammillary bodies or hippocampus. Compared with
young rats, NTproCNP was increased in occipital cortex, and
decreased in medial prefrontal cortex. Moreover, modifications
to NTproCNP seen in young rats within retrosplenial cortex
and dorsal hippocampus were not evident in aged rats. Varying
combinations of changes to degradation and production in aged
rats also resulted in increased concentrations of CNP in the
aging occipital and retrosplenial cortices. Overall, these results
indicate age-related modification to both the CNP signaling
system broadly, and its response to environmental conditions.
In addition, they indicate degradation or clearance rate to be an
important factor in determining bioactivity within neural tissue.
Previous work has shown that 2 weeks of enrichment
is sufficient to stimulate neural progenitor cell mobilization
(Magalon et al., 2007), upregulate multiple genes associated
with neuroplasticity in the hippocampus (Keyvani et al., 2004),
improve cognitive performance in intact animals (e.g., Tang et al.,
2001; Frick and Fernandez, 2003; Bruel-Jungerman et al., 2005)
and ameliorate cognitive deficits in animals with neurological
insults (e.g., Passineau et al., 2001; Hicks et al., 2002; Wagner
et al., 2002). Although here we have not explicitly linked increases
in CNP concentrations at this time point to other neurological
or behavioral sequelae, this finding encourages the view that the
peptide may contribute to such outcomes as part of the early
neurological response to enrichment in young rats. Interestingly,
the hippocampus is often a focus of structural and molecular
responses to enrichment (see Simpson and Kelly, 2011; Hirase
and Shinohara, 2014 for reviews), but here CNP exhibited the
smallest effect in terms of young rats’ response to short-term
enriched housing. Plausibly, the size of this effect may vary
throughout the hippocampal complex. Within hippocampus,
CNP mRNA predominates in CA1 through CA3, whereas NPR-
B mRNA is largely expressed within DG (Langub et al., 1995b;
Herman et al., 1996). Substantive changes to bioactive CNP in
any specific region similar to those in other regions of interest
analyzed here may be masked by the inclusion of all three
subregions used for hippocampal tissue analysis. This highlights
a need within future studies of CNP to consider these sub-
regions independently. Interestingly, an effect of enrichment on
NTproCNP concentrations was seen in dorsal hippocampus for
NTproCNP concentrations, suggesting a modification to gene
regulation as opposed to the effect seen on bioactive CNP in other
regions of interest. An explanation for this cannot be generated
from this data. Future work may consider the use of PCR to
analyse gene expression of Nppc directly, alongside NPR-B/NPR-
C and degradative enzyme (neprilysin and insulin-degrading
enzyme) gene expression to elucidate on the findings.
The relatively minimal response of aged rats to environmental
manipulations used here should now encourage further study
of the CNP signaling system in the aging brain. In a recent
review, Mahinrad et al. (2016) outline evidence suggesting
Natriuretic Peptides contribute to cognitive decline and
pathologies associated with aging, which we believe this
experimental work supports. Primarily, the lack of response to
enrichment of bioactive CNP in aged rats compared to young is
suggestive of age-related loss of sensitivity to external stimulus.
Additionally, evidence of loss or change in the NTproCNP
response to rehousing or enrichment in the aged retrosplenial
cortex, hippocampus and hypothalamus indicates age-related
modification to peptide production in these cortical nodes.
Apparent accumulation of CNP with aging in occipital and
retrosplenial cortices may align with the facilitation of long-
term depression with aging (Kelly et al., 2006). Notably, while
expected reductions to degradative activity were identified
in most regions, this effect was absent in hippocampus and
mammillary bodies, contrary to the hypothesis. Region specific,
age-related reductions in neprilysin (the proteolytic enzyme
regulating CNP) have been demonstrated previously within
hippocampus (Iwata et al., 2001, 2002; Yasojima et al., 2001a,b;
Higuchi et al., 2005; Hellström-Lindahl et al., 2008). Thus,
the absence of hypothesized reductions to degradative activity
within this region specifically raises interesting questions.
Because NTproCNP:CNP ratio is influenced by both proteolytic
enzyme activity and NPR-C clearance activity, one plausible
line of inquiry is to examine age-related modifications to this
receptor within hippocampus. Additionally, these age-related
changes to production, bioactive availability and degradation
or clearance of CNP should now be examined in association
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with other neurological factors wherein CNP may contribute to
cognitive decline such as modifications to synaptic regulation,
neurovascular function, anxiety, and memory (Mahinrad et al.,
2016). In this context it is relevant to note that in contrast
to other neuroprotective factors, the diverse molecular events
potentially regulated by CNP signaling—including ion channel
activity and cyclic AMP concentrations (Kuhn, 2016)—need to
be considered.
The major modification to CNP in medial prefrontal cortex
of aged rats seemingly related to the period of rehousing
with new cage mates rather than the rehousing environment.
Other minor modifications to measures from aged rats (not
directly reported here, but see Figures 1, 4 Aged-Standard
ratios; Figure 6 Aged-Standard NTproCNP for examples), also
generally related to rehousing period. Because CNP has been
previously related to anxiety regulation and related behaviors
(Bíró et al., 1996; Montkowski et al., 1998; Telegdy et al.,
1999, 2000; Jahn et al., 2001), this now encourages further
investigation of CNP in the context of anxiety and aging, because
this response in aged rats seems to relate to an anxious event
(rehousing with new cage mates). CNP’s effects on anxiety are
dependent on corticotropin releasing hormone (Jahn et al., 2001)
and medial prefrontal cortex, hippocampus and other limbic
system structures participate in regulation of the hypothalamo-
pituitary adrenal axis (Herman et al., 2005). Moreover, changes
to hypothalamo-pituitary adrenal axis signaling are thought
to contribute to neurological and behavioral changes during
aging (Mizoguchi et al., 2009; Swaab and Bao, 2011) as are
molecular and physiological changes throughout these same
frontal and temporal cortical networks (Nestor et al., 2003).
Although anxious and mnemonic behaviors were not studied
here, age-related modifications to this peptide system identified
within fronto-temporal regions provides initial experimental
support for an association with cognitive decline (Mahinrad
et al., 2016). However, a lack of reported impairment in
cognition in the homozygous human loss-of-function mutation
of the NPR-B receptor (Wang et al., 2016) suggests at least
two additional caveats. First, is that this conclusion may be
limited to rodents. Cognitive and neurological effects have been
reported in rodents with a loss of NPR-B function (Tamura
et al., 2004; Barmashenko et al., 2014; Buttgereit et al., 2016).
Alternatively, it may be that the NPR-C receptor is of greater
importance in mediating central functions of CNP than is
currently believed, but suggested by others (Trachte, 2000, 2005;
Gong et al., 2017; Moghtadaei et al., 2017). Clearly further work
is required to clarify the importance of CNP and its receptors
in regulating neural function in both rodents and humans. As
the first report of CNP and related molecules within rodent
medial prefrontal cortex and retrosplenial cortex, and changes
to bioactive CNP during environmental stimulation, the current
findings now call for more focused studies of CNP activity,
function and receptor expression throughout these important
neural circuits.
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